Critical review and uncertainty analysis of factors influencing influenza transmission

Risk Analysis

Volumn 31, Issue 8, 2011, Pages 1226-1242

  Jones, Rachael M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Contact rates; Environmental mediation; Inactivation rate; Influenza; Transfer efficiency

Indexed keywords

CRITICAL REVIEW; DATA VARIABILITY; ENVIRONMENTAL MEDIATION; INACTIVATION RATE; INFLUENZA; MONTE CARLO; PUBLIC HEALTH; RELATIVE RISKS; RISK MODEL; TRANSFER EFFICIENCY; TWO STAGE;

DATA TRANSFER RATES; HEALTH RISKS; PUBLIC RISKS; RISK ASSESSMENT; VIRUSES;

UNCERTAINTY ANALYSIS;

DISEASE TRANSMISSION; EXPERIMENTAL STUDY; FUTURE PROSPECT; HEALTH RISK; INFECTIOUS DISEASE; INFLUENZA; LITERATURE REVIEW; MONTE CARLO ANALYSIS; PARAMETERIZATION; PUBLIC HEALTH; RISK FACTOR; SIZE DISTRIBUTION; TEMPORAL ANALYSIS; UNCERTAINTY ANALYSIS; VIRUS;

ARTICLE; DISEASE TRANSMISSION; HUMAN; INFLUENZA; MICROBIOLOGY; MONTE CARLO METHOD; ORTHOMYXOVIRUS; PANDEMIC; PUBLIC HEALTH; RISK ASSESSMENT; UNCERTAINTY; VIROLOGY;

ENVIRONMENTAL MICROBIOLOGY; HUMANS; INFLUENZA, HUMAN; MONTE CARLO METHOD; ORTHOMYXOVIRIDAE; PANDEMICS; PUBLIC HEALTH; RISK ASSESSMENT; UNCERTAINTY;

EID: 79960904554     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01598.x     Document Type: Article

References (91)

1. Centers for Disease Control and Prevention. Community Strategy for Pandemic Influenza Mitigation, 2009. Available at:, Accessed September 15, 2009.
2. Institute of Medicine Committee on Personal Protective Equipment for Healthcare Workers During an Influenza Pandemic. Preparing for an Influenza Pandemic: Personal Protective Equipment for Healthcare Workers. Washington, DC National Academies Press, 2007.
3. Institute of Medicine Committee on Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A. Respiratory Protection for Healthcare Workers in the Workplaces Against Novel N1H1 Influenza A. Washington, DC National Academies Press, 2009.
4. Collin N, de Radigues X, and the World Health Organization H1N1 Vaccine Task Force. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine, 2009; 27:5184-5186.
5. Medlock J, Meyers LA, Galvani A. Optimizing allocation for a delayed influenza vaccination campaign. PLoS Currents: Influenza, 2009; RRN1134.
6. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clinic Proceedings, 2010; 85:64-76.
7. Patel A, Gorman SE. Stockpiling antiviral drugs for the next influenza pandemic. Nature, 2009; 86:241-243.
8. Dimitrov N, Goll S, Meyers LA, Pourbohloul B, Hupert N. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic (H1N1) influenza, 2009. PLoS Currents: Influenza, 2009; RRN1127.
9. Fabian P, McDevitt JJ, DeHaan WH, Fung RPO, Cowling BJ, Chan KH, Leung GM, Milton DK. Influenza virus in human exhaled breath: An observational study. PLoS One, 2008; 3:e2691.
10. Stelzer-Braid S, Oliver BG, Blazey AJ, Argent E, Newsome TP, Ralwingson WD, Tovey ER. Exhalation of respiratory viruses by breathing, coughing and talking. Journal of Medical Virology, 2009; 81:1674-1679.
11. Olofsson S, Kumlin U, Dimock K, Arnberg N. Avian influenza and sialic acid receptors: More than meets the eye Lancet Infectious Diseases, 2005; 5:184-188.
12. Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM. Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract. Journal of Virology, 2009; 83:7075-7084.
13. Hinds WC. Aerosol Technology: Properties, Behavior and Measurement of Airborne Particles, 2nd Edition. New York John Wiley & Sons, Inc, 1999.
14. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Influenza virus receptors in the human airway: Avian and human flu viruses seem to target different regions of a patient's respiratory tract. Nature, 2006; 440:435-436.
15. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. H5N1 virus attachment to lower respiratory tract. Science, 2006; 312:399.
16. van Riel D, Munster VJ, de Wit E, Rimmelzwaan FG, Fouchier RAM, Osterhaus ADME, Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. American Journal of Pathology, 2007; 171:1215-1223.
17. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, Subbarao K, Barclay WS, Pickles RJ. Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathogens, 2009; 5:31000424.
18. Alford RH. An attempt at protection of man against virulent influenza using nasal instillation of inactivated virus. Annals of Internal Medicine, 1965; 62:1312-1314.
19. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proceedings of the Society for Experimental Biology and Medicine, 1966; 122:800-804.
20. Nicas M, Jones RM. The relative contributions of four exposure pathways to influenza infection risk. Risk Analysis, 2009; 29:1292-1303.
21. Mubareka S, Lowen AC, Steel J, Coates AL, García-Sastre A, Palese P. Transmission of influenza virus via aerosols and fomites in the guinea pig model. Journal of Infectious Diseases, 2009; 199:858-865.
22. Atkinson MP, Wein LM. Quantifying the routes of transmission for pandemic influenza. Bulletin of Mathematical Biology, 2008; 70:820-867.
23. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Scalia Tomba G, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine, 2008; 5:e74.
24. Bernard H, Fischer R, Mikolajczyk RT, Kretzschmar M, Wildner M. Nurses' contacts and potential for infectious disease transmission. Emerging Infectious Diseases, 2009; 15:1438-1444.
25. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiology, 2006; 164:936-944.
26. Hens N, Goeyvaerts N, Aerts M, Shkedy Z, van Damme P, Beutels P. Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium. BMC Infectious Diseases, 2009; 9:5. doi:.
27. Chao CYH, Wan MP. A study of the dispersion of respiratory aerosols in unidirectional downward and ceiling-return type airflows using a multiphase approach. Indoor Air, 2006; 16:296-312.
28. Li Y, Leung GM, Tang JW, Yang X, Chao CYH, Lin JZ, Lu JW, Nielsen PV, Niu J, Wian H, Sleight, Su HJJ, Sundell J, Wong TW, Yuen PL. Role of ventilation in airborne transmission of infectious agents in the built environment: A multidisciplinary systematic review. Indoor Air, 2007; 17:2-18.
29. Chao CYH, Wan MP, Sze To GN. Transport and removal of expiratory droplets in hospital ward environment. Aerosol Science and Technology, 2008; 42:377-394.
30. Pantelic J, Sze To GN, Tham KW, Chao CYH, Khoo YCM. Personalized ventilation as a control measure for airborne transmissible disease spread. Journal of Royal Society Interface, 2009; 6:S715-S726.
31. National Research Council. Science and Decisions: Advancing Risk Assessment. Washington, DC National Academies Press, 2009.
32. Cullen AC, Frey HC. Probabilistic Techniques in Exposure Assessment. New York Plenum Press, 1999.
33. R Development Core Team. R: A Language and Environment for Statistical Computing. Available at:. Accessed on February 23, 2011.
34. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York Chapman & Hall, 1993.
35. Crawley MJ. The R Book. West Sussex, UK: John Wiley & Sons, Ltd, 2007.
36. Cao B, Li XW, Shu Y, Jiang N, Chen S, Xu X, Wang C, and for the National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of the 2009 pandemic influenza A (H1N1) virus infection in China. New Eng J Med, 2009; 361:2507-2517.
37. Al Kuwaitir TS, Al Abdulkarim AS, Abba AA, Yousef AM, El-Din MA, Rahman KT, Ali MA, Mohamed ME, Arnous NE. H1N1 influenza A: Preliminary evaluation in hospitalized patients in a secondary care facility in Saudi Arabia. Saudi Medical Journal, 2009; 30:1532-1536.
38. Kuhn JJ, Hendley JO, Adams KF, Clark JW, Gwaltney Jr. JM. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, 1982; 82:713-718.
39. Paul IM, Wai K, Jewell SJ, Schaffer ML, Varadan VV. Evaluation of a new self-contained, ambulatory, objective cough monitor. Cough, 2006; 2:7. doi:.
40. Loudon RG, Brown LC. Cough frequency in patients with respiratory disease. American Review of Respiratory Diseases, 1967; 96:1137-1143.
41. Yang S, Lee GWM, Chen CM, Wu CC, Yu KP. The size and concentration of droplets generated by coughing in human subjects. Journal of Aerosol Medicine, 2007; 20:484-494.
42. Xie X, Li Y, Sun H, Liu L. Exhaled droplets due to talking and coughing. J Ro Soc Interface, 2009; 6:S703-S714.
43. Edwards DS, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. Proceedings of National Academy of Sciences USA, 2004; 101:17383-17388.
44. Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM. Characterization of exhaled particles from the healthy human lung: A systematic analysis in relation to pulmonary function variables. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2010; 23:371-379.
45. Johnson GR, Morawska L. The mechanism of breath aerosol formation. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2009; 22:229-237.
46. Wells WF. Airborne Contagion and Air Hygiene. Cambridge, MA Harvard University Press, 1955.
47. Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection Indoor Air, 2006; 16:335-347.
48. Wainwright CE, France MW, O'Rourke P, Anuj S, Kidd TJ, Nissen MD, Sloots TP, Coulter C, Ristovski Z, Hargreaves M, Rose BR, Harbour C, Bell SC, Fennelly KP. Cough-generated aerosols ofPsuedomonas aeruginosaand other Gram-negative bacteria from patients with cystic fibrosis. Thorax, 2009; 64:926-931.
49. Fennelly KP, Martyny JW, Fulton KE, Orme IM, Cave DM, Heifets LB. Cough-generated aerosols ofMycobacterium tuberculosis: A new method to study infectiousness. American Journal of Respiratory and Critical Care Medicine, 2004; 169:604-609.
50. Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: Emission of respirable pathogens. Journal of Occupational and Environmental Hygiene, 2005; 2:143-154.
51. Loudon RG, Roberts RM. Droplet expulsion from the respiratory tract. American Review of Respiratory Diseases, 196; 95:435-442.
52. Papenini RS, Rosenthal RS. The size distribution of droplets in the exhaled breath of healthy human subjects. Journal of Aerosol Medicine, 1997; 10:105-116.
53. Duguid JP. The size and duration of air-carriage of respiratory droplets and droplet-nuclei. Journal of Hygiene, 1946; 4:471-780.
54. Hamburger M, Robertson OH. Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. American Journal of Medicine, 1946; 4:690-701.
55. Jennison MW. Atomizing of mouth and nose secretions into the air as revealed by high-speed photography. Aerobiology, 1942; 106-128.
56. Chao CYH, Wan MP, Morawska L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Li Y, Xie X, Katoschevki D. Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. Aerosol Science, 2009; 40:122-133.
57. Morawksa L, Johnson GR, Ristovski ZD, Hargreaves M, Mengersen K, Corbett S, Chao CYH, Li Y, Katoschevksi D. Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities. Aerosol Science, 2009; 40:256-269.
58. Zhu S, Kato S, Yang JH. Study of transport characteristics of saliva droplets produced by coughing in a calm indoor environment. Build Environment, 2006; 41:1691-1702.
59. Treanor JJ, Hayden FG, Vrooman PS, Barabarsh R, Bettis R, Riff D, Singh S, Knersley N, Ward P, Mills RG, for the US Oral Neuraminidase Study Group. Efficacy and safety of the oral neuraminidase inhibitor Oseltamivir in treating acute influenza. JAMA, 2000; 283:1016-1024.
60. Lee N, Chan PKS, Hui DSC, Rainer TH, Wong E, Choi KW, Lui GCY, Wong BCK, Wong RYK, Lam WY, Chu IMT, Lai RWM, Cockram CS, Sung JJY. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. Journal of Infectious Diseases, 2009; 200:492-500.
61. Harper GJ. Airborne micro-organisms: survival tests with four viruses. Journal of Hygiene, 1961; 59:479-486.
62. Hemmes JH, Winkler KC, Kool SM. Virus survival as a seasonal factor in influenza and poliomyelitis. Nature, 1960; 188:430-431.
63. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour Jr. HH. Survival of influenza viruses on environmental surfaces. Journal of Infectious Diseases, 1982; 146:47-51.
64. Thomas Y, Vogel G, Wunderli W, Suter P, Witschi M, Koch D, Tapparel C, Kaiser L. Survival of influenza virus on banknotes. Applied and Environmental Microbiology, 2008; 74:3002-3007.
65. Tiwari A, Patnayak DP, Chander Y, Parsad M, Goyal SM. Survival of two avian respiratory viruses on porous and nonporous surfaces. Avian Diseases, 2006; 50:284-287.
66. Sizun J, Yu MWN, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: A possible source of hospital-acquired infections. Journal of Hospital Infection, 2000; 46:55-60.
67. Brady MT, Evans J, Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces. American Journal of Infection Control, 1990; 18:18-23.
68. Buckland FE, Tyrrell DAJ. Loss of infectivity on drying various viruses. Nature, 1962; 195:1063-1064.
69. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistantEnterococcusor the colonized patient's environment. Infection Control and Hospital Epidemiology, 2008; 29:149-154.
70. Ansari SA, Springthorpe VS, Sattar SA, Rivard S, Rahman M. Potential role of hands in the spread of respriatory viral infections: Studies with human parainfluenza virus 3 and rhinovirus 14. Journal of Clinical Microbiology, 1991; 29:2115-2119.
71. Ansari SA, Sattar SA, Springthorpe VS, Wlles GA, Tostowaryk W. Survival of human hands and its transfer on contact with animate and inanimate surfaces. Journal of Clinical Microbiology, 1988; 30:757-763.
72. Mbithi JN, Springthorpe VS, Boulet JR, Sattar SA. Survival of hepatitis A on human hands and its transfer on contact with animate and inanimate surfaces. Journal of Clinical Microbiology, 1992; 30:757-763.
73. Julian TR, Canales RA, Leckie JO, Boehm AB. A model of exposure to rotavirus from nondietary ingestion iterated by simulated intermittent contacts. Risk Analysis, 2009; 25:617-631.
74. Pancic F, Carpentier DC, Came PE. Role of infectious secretions in the transmission of rhinovirus. Journal of Clinical Microbiology, 1098; 12:567-571.
75. Rusin P, Maxwell S, Gerba C. Comparative surface-to-hand and fingertip-to-mouth transfer efficiency of gram-positive bacteria, gram-negative bacteria, and phage. Journal of Applied Microbiology, 2002; 93:585-592.
76. Rheinbaben FV, Shcünemann S, Grob T, Wolff MH. Transmission of viruses via contact in a household setting: Experiments using bacteriophageΦX174as a model virus. Journal of Hospital Infection, 2000; 46:61-66.
77. van Cuyk S, Siegrist RL, Lowe K, Harvey RW. Evaluating microbial purification during soil treatment of wastewater with multicomponent tracer and surrogate tests. Journal of Environmental Quality, 2004; 33:316-329.
78. Nicas M, Best D. A study quantifying the hand-to-face contact rate and its potential application to predicting respiratory tract infection. Journal of Occupational and Environmental Hygiene, 2008; 5:347-352.
79. Hendley JO, Wenzel RP, Gwaltney JM. Transmission of rhinovirus colds by self-inoculation. New England Journal of Medicine, 1973; 288:1361-1364.
80. Xue J, Zartarian V, Moya J, Freeman N, Beamber P, Black K, Tulve N, Shalat S. A meta-analysis of children's hand-to-mouth frequnecy data for estimating nondietary ingestion exposure. Risk Analysis, 2007; 27:411-420.
81. Xue J, Zartarian V, Tulve N, Moya J, Freeman N, Auyeung W, Beamer P. A meta-analysis of children's object-to-mouth frequency data for estimating non-dietary ingestion exposure. Journal of Exposure Science and Environmental Epidemiology, 2010; 20:536-545.
82. Cowling BJ, Fung RO, Cheng CK, Fang VJ, Chan KH, Seto WH, Yung R, Chiu B, Lee P, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One, 2008; 3:e2102.
83. MacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G, Gasher M, Wood J, Gao Z, Booy R, Ferguson N. Face mask use and control of respiratory virus transmission in households. Emerging Infectious Diseases, 2009; 15:233-241.
84. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, Webby R, Smieja M, Earn DJD, Chong S, Webb A, Walter SD. Surgical mask vs N95 respirator for preventing influenza among health care workers: A randomized trial. JAMA, 2009; 302:1865-1871.
85. Jefferson T, Del Mar C, Dooley L, Cochrane Acute Respiratory Infectious Group, Ferroni E, Al Ansary LA, Bahamdan SAS, Bawazeer GA, van Driefl ML, Foxlee R, Rivetti A. Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review. BMJ, 2009; 339:b3675.
86. Wein LM, Atkinson MP. Assessing infection control measures for pandemic influenza. Risk Analysis, 2009; 29:949-962.
87. Li S, Eisenberg JNS, Spicknall IH, Kooman JS. Dynamics and control of infections transmitted from person to person through the environment. American Journal of Epidemiology, 2009; 17:257-265.
88. Blanchere FM, Lindsley WG, Pearce TA, Anderson SE, Fisher M, Khakoo R, Meade BJ, Lander O, Davis S, Thewlis RE, Celik I, Chen BT, Beezhold DH. Measurement of airborne influenza virus in a hospital emergency department. Clinical Infectious Diseases, 2009; 48:438-440.
89. Edward DG, Elford WJ, Laidlaw PP. Studies on airborne virus infections I. Experimental technique and preliminary observations on influenza and infectious ectromelia. Journal of Hygiene, 1943; 43:1-10.
90. Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent upon relative humidity and temperature. PLoS Pathogene, 2007; 3:e151.
91. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30°C) blocks aerosol but not contact transmission of influenza virus. Journal of Virology, 2008; 82:5650-5652.